Milpitas, CA, United States of America

Ruby Yanru Tsai

This inventor holds 1 USPTO granted patent. Top assignee: Abcam Plc. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruby Yanru Tsai. Retrieved from https://idiyas.com/inventor/ruby-yanru-tsai-n17cmkyu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ruby Yanru Tsai

Introduction

Ruby Yanru Tsai is an accomplished inventor based in Milpitas, California. She has made significant contributions to the field of genetic engineering, particularly through her innovative work involving CRISPR technology. Her research focuses on developing advanced methods for integrating transgenes, which have important implications for gene therapy and cell therapy.

Latest Patents

Ruby Yanru Tsai holds a patent for her invention titled "Site-directed CRISPR/recombinase compositions and methods of integrating transgenes." This patent discloses targeted chimeric polypeptides, compositions thereof, expression vectors, and methods for generating transgenic cells, tissues, plants, and animals. The invention is particularly useful in gene therapy and cell therapy techniques, showcasing the potential for significant advancements in medical science.

Career Highlights

Ruby is currently associated with Abcam Plc, a company known for its commitment to providing high-quality research tools. Her role at Abcam allows her to further her research and contribute to the development of innovative solutions in the life sciences sector.

Conclusion

Ruby Yanru Tsai exemplifies the spirit of innovation in the field of genetic engineering. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…